search
Back to results

Pre-induction Analgesia: Multimodel Regimen vs Aceteminophen for Post Ureteroscopy Pain (MMPITR)

Primary Purpose

Kidney Calculi, Pain, Postoperative

Status
Withdrawn
Phase
Phase 4
Locations
Study Type
Interventional
Intervention
Multimodal Oral Drug Regimen
Acetaminophen
Sponsored by
Kevin J Flynn MD
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Kidney Calculi focused on measuring ureteroscopy, opioids, narcotics, text messaging, real time data acquisition, ecologic momentary assessments, pre-emptive analgesia, gabapentin, meloxicam, tamsulosin, kidney stones, lithotripsy, nephrolithiasis

Eligibility Criteria

18 Years - 100 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Adult Patient (greater than 18 years old)
  • Possesses or has access to cell phone with text message capability
  • Undergoing ureteroscopy with lithotripsy for a ureteral or kidney stones

Exclusion Criteria:

  • Does not possess or have access to a cell phone with text message capability
  • Non-English speaking
  • Incarcerated individuals
  • undergoing planned secondary procedure
  • pregnancy
  • intellectual disability
  • History of, anaphylactic, rash, or other hypersensitivity reaction to any of the study agents
  • Patients with history of CABG, myocardial infarction, endovascular cardiac stent, gastrointestinal bleed, or gastric ulcer disease will not receive Celecoxib. They may still participate in the study otherwise, it will be documented that they did not receive an NSAID component.

Sites / Locations

    Arms of the Study

    Arm 1

    Arm 2

    Arm Type

    Experimental

    Active Comparator

    Arm Label

    Multimodel Drug Regimen

    Acetaminophen Only

    Arm Description

    The patients randomized to this arm will receive the following multimodal oral drug regimen administered shortly before induction of general anesthesia Tylenol, 975mg (3 tabs) 800mg Gabapentin 400mg Celecoxib 10mg Oxycodone

    The patients randomized to this arm will receive oral acetaminophen only administered shortly before induction of general anesthesia 1. Tylenol, 975mg (3 tabs)

    Outcomes

    Primary Outcome Measures

    Postoperative day 0 Pain
    The magnitude of pain (0-10) that the patient experiences in the evening after their surgery concludes

    Secondary Outcome Measures

    Time to pain resolution
    The amount of time (days) that it takes for patients to report a pain level of less than 4 (0-10 scale)
    Opioid Consumption
    The number of total opioid pills a patient consumes following surgery
    Time to complete pain resolution
    The amount of time (days) that it takes for patients to report a pain level of 0 (0-10 scale)

    Full Information

    First Posted
    May 25, 2018
    Last Updated
    December 21, 2018
    Sponsor
    Kevin J Flynn MD
    search

    1. Study Identification

    Unique Protocol Identification Number
    NCT03549611
    Brief Title
    Pre-induction Analgesia: Multimodel Regimen vs Aceteminophen for Post Ureteroscopy Pain
    Acronym
    MMPITR
    Official Title
    Randomized Comparison of Two Pre-induction Analgesia Regimens: Multimodal vs Acetaminophen in the Reduction of Post-operative Pain Following Ureteroscopy With Lithotripsy for Kidney Stones Evaluated With Text Messaging
    Study Type
    Interventional

    2. Study Status

    Record Verification Date
    December 2018
    Overall Recruitment Status
    Withdrawn
    Why Stopped
    elected not to proceed with the study
    Study Start Date
    August 1, 2018 (Anticipated)
    Primary Completion Date
    June 30, 2019 (Anticipated)
    Study Completion Date
    June 30, 2019 (Anticipated)

    3. Sponsor/Collaborators

    Responsible Party, by Official Title
    Sponsor-Investigator
    Name of the Sponsor
    Kevin J Flynn MD

    4. Oversight

    Studies a U.S. FDA-regulated Drug Product
    Yes
    Studies a U.S. FDA-regulated Device Product
    No
    Product Manufactured in and Exported from the U.S.
    Yes
    Data Monitoring Committee
    No

    5. Study Description

    Brief Summary
    Adult patients with kidney stones undergoing surgical intervention with ureteroscopy with laser lithotripsy will be randomized to receive one of two different regimens of oral medications administered prior to induction of general anesthesia. Postoperatively, patients will receive automated daily text messages to assess pain and opioid consumption and subsequently determine which which treatment regimen is superior.
    Detailed Description
    Adult patients undergoing ureteroscopy for kidney stones will be screened and those who meet initial study criteria (adult, English speaking, non-pregnant, non-intellectually disabled patients), will be sent an information letter outlining the study. Interested patients, who possess a phone capable of text messaging will be consented to enroll in the study and randomized to one of two preoperative analgesic treatment arms (see below) that will be administered in the preoperative area prior to induction of general anesthesia. Multimodal Analgesia Arm Acetaminophen 975mg Gabapentin 800mg Oxycodone 10mg Celecoxib 400mg Acetaminophen Only Analgesia Arm a. Acetaminophen 975mg Consenting patients will fill out a baseline demographics questionnaire as well as provide baseline levels of pain and opioid consumption prior to surgery. They will also be enrolled to receive automated postoperative pain assessments and opioid consumption inquiries via text message. The patients will be blinded to the treatment they are receiving. The research team will not be blinded. The patient will then proceed with their planned ureteroscopy. The patient will then undergo their planned ureteroscopy with lithotripsy for kidney stone disease; the study does not change any parameters about the surgery itself. The general anesthesia regimen will be standardized to one particular standard of care method so as to minimize the potential effect of confounders. All patients (patients in both preoperative analgesia treatment regimen arms) will be monitored in the post-anesthesia recovery unit for pain, blood pressure, sedation level monitored by the Ramsey Sedation Scale. Once they have recovered appropriately and met standard discharge criteria they will be discharged with the following analgesic regimen Tylenol 650 every 6 hours x 7 day Oxybutynin 5mg three times daily as needed for x 7 days Flomax 0.4mg daily x 7 days Oxycodone, 5mg as needed 15 pills Celecoxib daily for 7 days Patients will receive a pain assessment via text message the evening of postoperative day 0, and then twice a day for 14 days. Patients will also receive an opioid consumption inquiry once a day for 14 days. On postoperative day 15 patients will be asked if they were happy with their postoperative pain control. During the study period the research team will access the patients electronic medical record to review and record the following information Current medications height, weight, age, gender, marital status, city, state of residence Co-morbid medical conditions insurance stone parameters: size (mmm), location, laterality, number of stones, Operative factors: instruments used, operative time, operative complications post-operative course: emergency department visits, unexpected phone calls, unexpected clinic visits, other 30-day complications

    6. Conditions and Keywords

    Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
    Kidney Calculi, Pain, Postoperative
    Keywords
    ureteroscopy, opioids, narcotics, text messaging, real time data acquisition, ecologic momentary assessments, pre-emptive analgesia, gabapentin, meloxicam, tamsulosin, kidney stones, lithotripsy, nephrolithiasis

    7. Study Design

    Primary Purpose
    Treatment
    Study Phase
    Phase 4
    Interventional Study Model
    Parallel Assignment
    Masking
    Participant
    Masking Description
    The patient will not be made aware which treatment regimen they are receiving and neither will the attending urologist.
    Allocation
    Randomized
    Enrollment
    0 (Actual)

    8. Arms, Groups, and Interventions

    Arm Title
    Multimodel Drug Regimen
    Arm Type
    Experimental
    Arm Description
    The patients randomized to this arm will receive the following multimodal oral drug regimen administered shortly before induction of general anesthesia Tylenol, 975mg (3 tabs) 800mg Gabapentin 400mg Celecoxib 10mg Oxycodone
    Arm Title
    Acetaminophen Only
    Arm Type
    Active Comparator
    Arm Description
    The patients randomized to this arm will receive oral acetaminophen only administered shortly before induction of general anesthesia 1. Tylenol, 975mg (3 tabs)
    Intervention Type
    Drug
    Intervention Name(s)
    Multimodal Oral Drug Regimen
    Other Intervention Name(s)
    Gabapentin 800mg, Oxycodone 10mg, Acetaminophen 975mg, Celecoxib 400mg
    Intervention Description
    Regimen of 4 pharmacologic agents that provides analgesia by acting on 4 different physiologic pain pathways
    Intervention Type
    Drug
    Intervention Name(s)
    Acetaminophen
    Other Intervention Name(s)
    Tylenol
    Intervention Description
    Acetaminophen 975mg
    Primary Outcome Measure Information:
    Title
    Postoperative day 0 Pain
    Description
    The magnitude of pain (0-10) that the patient experiences in the evening after their surgery concludes
    Time Frame
    4-6 hours after conclusion of surgery
    Secondary Outcome Measure Information:
    Title
    Time to pain resolution
    Description
    The amount of time (days) that it takes for patients to report a pain level of less than 4 (0-10 scale)
    Time Frame
    Approximately the first 72-96 hours
    Title
    Opioid Consumption
    Description
    The number of total opioid pills a patient consumes following surgery
    Time Frame
    14 days following surgery
    Title
    Time to complete pain resolution
    Description
    The amount of time (days) that it takes for patients to report a pain level of 0 (0-10 scale)
    Time Frame
    14 days

    10. Eligibility

    Sex
    All
    Minimum Age & Unit of Time
    18 Years
    Maximum Age & Unit of Time
    100 Years
    Accepts Healthy Volunteers
    No
    Eligibility Criteria
    Inclusion Criteria: Adult Patient (greater than 18 years old) Possesses or has access to cell phone with text message capability Undergoing ureteroscopy with lithotripsy for a ureteral or kidney stones Exclusion Criteria: Does not possess or have access to a cell phone with text message capability Non-English speaking Incarcerated individuals undergoing planned secondary procedure pregnancy intellectual disability History of, anaphylactic, rash, or other hypersensitivity reaction to any of the study agents Patients with history of CABG, myocardial infarction, endovascular cardiac stent, gastrointestinal bleed, or gastric ulcer disease will not receive Celecoxib. They may still participate in the study otherwise, it will be documented that they did not receive an NSAID component.
    Overall Study Officials:
    First Name & Middle Initial & Last Name & Degree
    Chad Tracy, MD
    Organizational Affiliation
    University of Iowa Department of Urology
    Official's Role
    Principal Investigator

    12. IPD Sharing Statement

    Plan to Share IPD
    No
    IPD Sharing Plan Description
    Data will not be shared
    Citations:
    PubMed Identifier
    22323972
    Citation
    Ahn ST, Kim JH, Park JY, Moon du G, Bae JH. Acute postoperative pain after ureteroscopic removal of stone: incidence and risk factors. Korean J Urol. 2012 Jan;53(1):34-9. doi: 10.4111/kju.2012.53.1.34. Epub 2012 Jan 25.
    Results Reference
    background
    PubMed Identifier
    25537330
    Citation
    Penprase B, Brunetto E, Dahmani E, Forthoffer JJ, Kapoor S. The efficacy of preemptive analgesia for postoperative pain control: a systematic review of the literature. AORN J. 2015 Jan;101(1):94-105.e8. doi: 10.1016/j.aorn.2014.01.030.
    Results Reference
    background
    PubMed Identifier
    22498635
    Citation
    Scales CD Jr, Smith AC, Hanley JM, Saigal CS; Urologic Diseases in America Project. Prevalence of kidney stones in the United States. Eur Urol. 2012 Jul;62(1):160-5. doi: 10.1016/j.eururo.2012.03.052. Epub 2012 Mar 31.
    Results Reference
    background
    PubMed Identifier
    25219700
    Citation
    Oberlin DT, Flum AS, Bachrach L, Matulewicz RS, Flury SC. Contemporary surgical trends in the management of upper tract calculi. J Urol. 2015 Mar;193(3):880-4. doi: 10.1016/j.juro.2014.09.006. Epub 2014 Sep 16.
    Results Reference
    background
    PubMed Identifier
    24765679
    Citation
    Barnes KT, Bing MT, Tracy CR. Do ureteric stent extraction strings affect stent-related quality of life or complications after ureteroscopy for urolithiasis: a prospective randomised control trial. BJU Int. 2014 Apr;113(4):605-9. doi: 10.1111/bju.12541.
    Results Reference
    background
    PubMed Identifier
    29340270
    Citation
    Hirschtritt ME, Delucchi KL, Olfson M. Outpatient, combined use of opioid and benzodiazepine medications in the United States, 1993-2014. Prev Med Rep. 2017 Dec 21;9:49-54. doi: 10.1016/j.pmedr.2017.12.010. eCollection 2018 Mar.
    Results Reference
    background

    Learn more about this trial

    Pre-induction Analgesia: Multimodel Regimen vs Aceteminophen for Post Ureteroscopy Pain

    We'll reach out to this number within 24 hrs